Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocol.
Takeuchi S, Murayama T, Yoshimura K, Kawakami T, Takahara S, Imai Y, Kuribayashi Y, Nagase K, Goto K, Nishio M, Hasegawa Y, Satouchi M, Kiura K, Seto T, Yano S.
Takeuchi S, et al. Among authors: kuribayashi y.
J Med Invest. 2017;64(3.4):317-320. doi: 10.2152/jmi.64.317.
J Med Invest. 2017.
PMID: 28955006
Free article.
Clinical Trial.